Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Excess nicotinamide inhibits methylation-mediated degradation of catecholamines in normotensives and hypertensives.

Sun WP, Li D, Lun YZ, Gong XJ, Sun SX, Guo M, Jing LX, Zhang LB, Xiao FC, Zhou SS.

Hypertens Res. 2012 Feb;35(2):180-5. doi: 10.1038/hr.2011.151. Epub 2011 Sep 15.

PMID:
21918528
2.

Excess nicotinamide increases plasma serotonin and histamine levels.

Tian YJ, Li D, Ma Q, Gu XY, Guo M, Lun YZ, Sun WP, Wang XY, Cao Y, Zhou SS.

Sheng Li Xue Bao. 2013 Feb 25;65(1):33-8.

3.

Effects of nisoldipine on stress-induced changes in haemodynamics and plasma catecholamines in normotensives and hypertensives.

Ludwig J, Gerhardt T, Halbrügge T, Walter J, Heidbreder E, Graefe KH.

J Hum Hypertens. 1990 Dec;4(6):693-701.

PMID:
2096212
4.

Comparison of the effects of nicotinic acid and nicotinamide degradation on plasma betaine and choline levels.

Sun WP, Zhai MZ, Li D, Zhou Y, Chen NN, Guo M, Zhou SS.

Clin Nutr. 2017 Aug;36(4):1136-1142. doi: 10.1016/j.clnu.2016.07.016. Epub 2016 Aug 10.

PMID:
27567458
5.

Augmented sympathetic nerve activity in response to stressors in young borderline hypertensive men.

Matsukawa T, Gotoh E, Uneda S, Miyajima E, Shionoiri H, Tochikubo O, Ishii M.

Acta Physiol Scand. 1991 Feb;141(2):157-65.

PMID:
2048404
6.

Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines.

Guasti L, Marino F, Gaudio G, Cosentino M, Diolisi A, Bertolini A, Grandi AM, Lecchini S, Frigo G, Venco A.

Acta Cardiol. 1997;52(6):485-94.

PMID:
9542574
7.

Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats.

Li D, Tian YJ, Guo J, Sun WP, Lun YZ, Guo M, Luo N, Cao Y, Cao JM, Gong XJ, Zhou SS.

Br J Nutr. 2013 Dec;110(12):2156-64. doi: 10.1017/S0007114513001815. Epub 2013 Jun 17.

PMID:
23768418
8.

Plasma catecholamines and essential hypertension. An analytical review.

Goldstein DS.

Hypertension. 1983 Jan-Feb;5(1):86-99. Review.

9.
10.

The relationships of free to conjugated normetanephrine in plasma and spinal fluid of hypertensive patients.

Foti A, Adachi M, DeQuattro V.

J Clin Endocrinol Metab. 1982 Jul;55(1):81-5.

PMID:
7076810
11.

Plasma homocysteine concentration and blood pressure in young adult African Americans.

Dinavahi R, Cossrow N, Kushner H, Falkner B.

Am J Hypertens. 2003 Sep;16(9 Pt 1):767-70.

PMID:
12944036
12.
13.
14.

Diurnal rhythms of blood pressure, plasma renin activity, angiotensin II and catecholamines in normotensive and hypertensive pregnancies.

Beilin LJ, Deacon J, Michael CA, Vandongen R, Lalor CM, Barden AE, Davidson L, Rouse I.

Clin Exp Hypertens B. 1983;2(2):271-93.

PMID:
6347445
15.
16.

Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.

Solt VB, Brown MR, Kennedy B, Kolterman OG, Ziegler MG.

Am J Hypertens. 1990 Nov;3(11):823-8.

PMID:
2261148
17.

Relationship of homocysteine with cardiovascular disease and blood pressure.

Dinavahi R, Falkner B.

J Clin Hypertens (Greenwich). 2004 Sep;6(9):494-8; quiz 499-500. Review.

19.

Plasma metanephrines in renal failure.

Eisenhofer G, Huysmans F, Pacak K, Walther MM, Sweep FC, Lenders JW.

Kidney Int. 2005 Feb;67(2):668-77.

20.

Anxiety, anger, and neurogenic tone at rest and in stress in patients with primary hypertension.

Sullivan P, Schoentgen S, DeQuattro V, Procci W, Levine D, Van der Meulen J, Bornheimer J.

Hypertension. 1981 Nov-Dec;3(6 Pt 2):II-119-23.

PMID:
7298129

Supplemental Content

Support Center